Hui A C F, Wong S, Leung C H, Tong P, Mok V, Poon D, Li-Tsang C W, Wong L K, Boet R
Division of Neurology, Department of Medicine, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong, China.
Neurology. 2005 Jun 28;64(12):2074-8. doi: 10.1212/01.WNL.0000169017.79374.93.
Decompressive surgery and steroid injection are widely used forms of treatment for carpal tunnel syndrome (CTS) but there is no consensus on their effectiveness in comparison to each other. The authors evaluated the efficacy of surgery vs steroid injection in relieving symptoms in patients with CTS.
The authors conducted a randomized, single blind, controlled trial. Fifty patients with electrophysiologically confirmed idiopathic CTS were randomized and assigned to open carpal tunnel release (25 patients) or to a single injection of steroid (25 patients). Patients were followed up at 6 and 20 weeks. The primary outcome was symptom relief in terms of the Global Symptom Score (GSS), which rates symptoms on a scale of 0 (no symptoms) to 50 (most severe). Nerve conduction studies and grip strength measurements were used as secondary outcome assessments.
At 20 weeks after randomization, patients who underwent surgery had greater symptomatic improvement than those who were injected. The mean improvement in GSS after 20 weeks was 24.2 (SD 11.0) in the surgery group vs 8.7 (SD 13.0) in the injection group (p < 0.001); surgical decompression also resulted in greater improvement in median nerve distal motor latencies and sensory nerve conduction velocity. Mean grip strength in the surgical group was reduced by 1.7 kg (SD 5.1) compared with a gain of 2.4 kg (SD 5.5) in the injection group.
Compared with steroid injection, open carpal tunnel release resulted in better symptomatic and neurophysiologic outcome but not grip strength in patients with idiopathic carpal tunnel syndrome over a 20-week period.
减压手术和类固醇注射是腕管综合征(CTS)广泛使用的治疗方式,但关于它们彼此之间有效性的比较尚无共识。作者评估了手术与类固醇注射对CTS患者症状缓解的疗效。
作者进行了一项随机、单盲、对照试验。50例经电生理确诊的特发性CTS患者被随机分组,分别接受开放性腕管松解术(25例患者)或单次类固醇注射(25例患者)。在6周和20周时对患者进行随访。主要结局是根据全球症状评分(GSS)评估的症状缓解情况,该评分将症状按0(无症状)至50(最严重)进行分级。神经传导研究和握力测量用作次要结局评估。
随机分组后20周,接受手术的患者症状改善程度大于接受注射的患者。手术组20周后GSS的平均改善值为24.2(标准差11.0),而注射组为8.7(标准差13.0)(p<0.001);手术减压还使正中神经远端运动潜伏期和感觉神经传导速度有更大改善。手术组的平均握力下降了1.7kg(标准差5.1),而注射组增加了2.4kg(标准差5.5)。
与类固醇注射相比,在20周期间,开放性腕管松解术在特发性腕管综合征患者中产生了更好的症状和神经生理学结局,但握力方面未显示优势。